Putnam BioRevolution ETF (SYNB)

Assets	$5.28M
Expense Ratio	0.71%
PE Ratio	36.23
Shares Out	175,000
Dividend (ttm)	$0.21
Dividend Yield	0.71%
Ex-Dividend Date	Dec 5, 2024
Payout Ratio	25.75%
1-Year Return	+5.34%

Volume	428
Open	30.11
Previous Close	30.11
Day's Range	30.11 - 30.11
52-Week Low	28.34
52-Week High	33.23
Beta	1.01
Holdings	36
Inception Date	Sep 29, 2022

About SYNB

Fund Home Page

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is issued by Putnam.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: SYNB
• ETF Provider: Putnam

Top 10 Holdings

50.68% of assets

Name	Symbol	Weight
Thermo Fisher Scientific Inc.	TMO	6.76%
Danaher Corporation	DHR	6.25%
Bio-Rad Laboratories, Inc.	BIO	5.98%
NVIDIA Corporation	NVDA	5.66%
Corteva, Inc.	CTVA	4.76%
AbbVie Inc.	ABBV	4.73%
Novonesis A/S	NVZMY	4.52%
Alphabet Inc.	GOOGL	4.38%
Ascendis Pharma A/S	ASND	3.92%
AstraZeneca PLC	AZN	3.72%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 5, 2024	$0.214	Dec 9, 2024
Dec 6, 2023	$0.021	Dec 11, 2023